Incyte Capex To Revenue vs Cost Of Revenue Analysis

INCY Stock

USD 69.84 0.07 0.10%

Incyte financial indicator trend analysis is infinitely more than just investigating Incyte recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Incyte is a good investment. Please check the relationship between Incyte Capex To Revenue and its Cost Of Revenue accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Incyte. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

For more information on how to buy Incyte Stock please use our How to Invest in Incyte guide.

Capex To Revenue vs Cost Of Revenue

Capex To Revenue vs Cost Of Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Incyte Capex To Revenue account and Cost Of Revenue. At this time, the significance of the direction appears to have significant contrarian relationship.

The correlation between Incyte's Capex To Revenue and Cost Of Revenue is -0.32. Overlapping area represents the amount of variation of Capex To Revenue that can explain the historical movement of Cost Of Revenue in the same time period over historical financial statements of Incyte, assuming nothing else is changed. The correlation between historical values of Incyte's Capex To Revenue and Cost Of Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Capex To Revenue of Incyte are associated (or correlated) with its Cost Of Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cost Of Revenue has no effect on the direction of Capex To Revenue i.e., Incyte's Capex To Revenue and Cost Of Revenue go up and down completely randomly.

Correlation Coefficient

-0.32

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Capex To Revenue

The ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets.

Cost Of Revenue

Cost of Revenue is found on Incyte income statement and represents the costs associated with goods and services Incyte provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Most indicators from Incyte's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Incyte current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Incyte. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

For more information on how to buy Incyte Stock please use our How to Invest in Incyte guide.At this time, Incyte's Selling General Administrative is fairly stable compared to the past year. Tax Provision is likely to rise to about 229.8 M in 2024, whereas Sales General And Administrative To Revenue is likely to drop 0.30 in 2024.

	2021	2022	2023	2024 (projected)
Total Operating Expenses	2.2B	2.6B	2.8B	3.0B
Cost Of Revenue	151.0M	207.0M	255M	267.8M

Total Operating Expenses Cost Of Revenue

Incyte fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Cash And Short Term Investments	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Non Currrent Assets Other	Net Receivables	Property Plant And Equipment Gross	Intangible Assets	Short Term Investments	Other Assets	Long Term Debt
Total Assets		-0.63	0.92	0.8	0.99	0.98	-0.98	0.64	0.79	0.99	0.99	0.99	0.52	-0.25	0.98	0.93	0.87	1.0	-0.39	0.85	0.99	0.99	0.39	0.92	0.88	-0.67
Short Long Term Debt Total	-0.63		-0.44	-0.21	-0.71	-0.67	0.73	-0.52	-0.53	-0.59	-0.64	-0.6	-0.18	0.78	-0.59	-0.63	-0.2	-0.61	0.71	-0.36	-0.67	-0.64	-0.44	-0.61	-0.47	0.95
Other Current Liab	0.92	-0.44		0.84	0.9	0.9	-0.87	0.73	0.7	0.92	0.92	0.91	0.34	-0.11	0.89	0.77	0.89	0.92	-0.24	0.89	0.93	0.94	0.17	0.79	0.93	-0.44
Total Current Liabilities	0.8	-0.21	0.84		0.74	0.76	-0.71	0.47	0.69	0.78	0.8	0.79	0.51	0.18	0.76	0.7	0.93	0.79	0.22	0.69	0.78	0.78	0.4	0.74	0.72	-0.24
Total Stockholder Equity	0.99	-0.71	0.9	0.74		0.98	-0.99	0.66	0.78	0.98	0.98	0.99	0.48	-0.35	0.97	0.93	0.81	0.99	-0.46	0.83	0.99	0.99	0.39	0.92	0.87	-0.74
Property Plant And Equipment Net	0.98	-0.67	0.9	0.76	0.98		-0.96	0.59	0.84	0.96	0.98	0.96	0.55	-0.3	0.94	0.94	0.83	0.97	-0.43	0.76	0.99	0.98	0.42	0.89	0.84	-0.71
Net Debt	-0.98	0.73	-0.87	-0.71	-0.99	-0.96		-0.66	-0.8	-0.98	-0.96	-0.98	-0.48	0.41	-0.97	-0.92	-0.78	-0.98	0.5	-0.81	-0.97	-0.97	-0.38	-0.88	-0.86	0.78
Retained Earnings	0.64	-0.52	0.73	0.47	0.66	0.59	-0.66		0.39	0.65	0.63	0.63	-0.25	-0.47	0.65	0.34	0.43	0.63	-0.37	0.73	0.62	0.68	-0.13	0.45	0.85	-0.45
Accounts Payable	0.79	-0.53	0.7	0.69	0.78	0.84	-0.8	0.39		0.78	0.77	0.78	0.61	-0.22	0.79	0.79	0.71	0.79	-0.29	0.43	0.8	0.74	0.47	0.65	0.68	-0.57
Cash	0.99	-0.59	0.92	0.78	0.98	0.96	-0.98	0.65	0.78		0.97	1.0	0.49	-0.25	0.98	0.91	0.87	1.0	-0.4	0.87	0.97	0.98	0.32	0.89	0.89	-0.64
Non Current Assets Total	0.99	-0.64	0.92	0.8	0.98	0.98	-0.96	0.63	0.77	0.97		0.97	0.5	-0.25	0.96	0.93	0.86	0.98	-0.38	0.83	0.99	0.99	0.44	0.92	0.87	-0.68
Cash And Short Term Investments	0.99	-0.6	0.91	0.79	0.99	0.96	-0.98	0.63	0.78	1.0	0.97		0.51	-0.23	0.98	0.93	0.88	1.0	-0.39	0.87	0.97	0.98	0.35	0.92	0.88	-0.65
Common Stock Shares Outstanding	0.52	-0.18	0.34	0.51	0.48	0.55	-0.48	-0.25	0.61	0.49	0.5	0.51		0.24	0.48	0.72	0.6	0.52	0.01	0.19	0.52	0.45	0.64	0.6	0.19	-0.28
Non Current Liabilities Total	-0.25	0.78	-0.11	0.18	-0.35	-0.3	0.41	-0.47	-0.22	-0.25	-0.25	-0.23	0.24		-0.28	-0.21	0.21	-0.25	0.68	-0.14	-0.29	-0.28	0.04	-0.15	-0.27	0.8
Other Current Assets	0.98	-0.59	0.89	0.76	0.97	0.94	-0.97	0.65	0.79	0.98	0.96	0.98	0.48	-0.28		0.9	0.86	0.98	-0.42	0.86	0.95	0.96	0.33	0.89	0.9	-0.66
Other Stockholder Equity	0.93	-0.63	0.77	0.7	0.93	0.94	-0.92	0.34	0.79	0.91	0.93	0.93	0.72	-0.21	0.9		0.81	0.93	-0.4	0.68	0.94	0.91	0.55	0.93	0.68	-0.71
Total Liab	0.87	-0.2	0.89	0.93	0.81	0.83	-0.78	0.43	0.71	0.87	0.86	0.88	0.6	0.21	0.86	0.81		0.87	0.01	0.8	0.84	0.85	0.36	0.82	0.78	-0.27
Total Current Assets	1.0	-0.61	0.92	0.79	0.99	0.97	-0.98	0.63	0.79	1.0	0.98	1.0	0.52	-0.25	0.98	0.93	0.87		-0.4	0.86	0.98	0.99	0.36	0.92	0.88	-0.66
Short Term Debt	-0.39	0.71	-0.24	0.22	-0.46	-0.43	0.5	-0.37	-0.29	-0.4	-0.38	-0.39	0.01	0.68	-0.42	-0.4	0.01	-0.4		-0.31	-0.42	-0.41	-0.03	-0.31	-0.35	0.71
Non Currrent Assets Other	0.85	-0.36	0.89	0.69	0.83	0.76	-0.81	0.73	0.43	0.87	0.83	0.87	0.19	-0.14	0.86	0.68	0.8	0.86	-0.31		0.82	0.88	0.02	0.77	0.87	-0.42
Net Receivables	0.99	-0.67	0.93	0.78	0.99	0.99	-0.97	0.62	0.8	0.97	0.99	0.97	0.52	-0.29	0.95	0.94	0.84	0.98	-0.42	0.82		0.99	0.39	0.91	0.87	-0.7
Property Plant And Equipment Gross	0.99	-0.64	0.94	0.78	0.99	0.98	-0.97	0.68	0.74	0.98	0.99	0.98	0.45	-0.28	0.96	0.91	0.85	0.99	-0.41	0.88	0.99		0.33	0.91	0.9	-0.67
Intangible Assets	0.39	-0.44	0.17	0.4	0.39	0.42	-0.38	-0.13	0.47	0.32	0.44	0.35	0.64	0.04	0.33	0.55	0.36	0.36	-0.03	0.02	0.39	0.33		0.51	0.02	-0.44
Short Term Investments	0.92	-0.61	0.79	0.74	0.92	0.89	-0.88	0.45	0.65	0.89	0.92	0.92	0.6	-0.15	0.89	0.93	0.82	0.92	-0.31	0.77	0.91	0.91	0.51		0.7	-0.63
Other Assets	0.88	-0.47	0.93	0.72	0.87	0.84	-0.86	0.85	0.68	0.89	0.87	0.88	0.19	-0.27	0.9	0.68	0.78	0.88	-0.35	0.87	0.87	0.9	0.02	0.7		-0.48
Long Term Debt	-0.67	0.95	-0.44	-0.24	-0.74	-0.71	0.78	-0.45	-0.57	-0.64	-0.68	-0.65	-0.28	0.8	-0.66	-0.71	-0.27	-0.66	0.71	-0.42	-0.7	-0.67	-0.44	-0.63	-0.48

Click cells to compare fundamentals

Incyte Account Relationship Matchups

Incyte fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	3.4B	3.6B	4.9B	5.8B	6.8B	7.1B
Short Long Term Debt Total	60.2M	34.9M	34.3M	44.6M	38.3M	36.4M
Other Current Liab	76.1M	517.5M	669.0M	861.0M	1.1B	1.1B
Total Current Liabilities	500.5M	648.8M	885.1M	1.2B	1.2B	1.3B
Total Stockholder Equity	2.6B	2.6B	3.8B	4.4B	5.2B	5.4B
Property Plant And Equipment Net	406.6M	588.1M	751.5M	765.6M	777.0M	815.9M
Net Debt	(1.8B)	(1.5B)	(2.0B)	(2.9B)	(3.2B)	(3.0B)
Retained Earnings	(1.4B)	(1.7B)	(777.9M)	(437.2M)	160.4M	168.4M
Accounts Payable	83.6M	98.8M	172.1M	277.5M	109.6M	115.1M
Cash	1.8B	1.5B	2.1B	3.0B	3.2B	3.4B
Non Current Assets Total	889.7M	1.1B	1.7B	1.6B	2.1B	2.2B
Cash And Short Term Investments	2.1B	1.8B	2.3B	3.2B	3.7B	3.8B
Common Stock Shares Outstanding	217.7M	218.1M	222.1M	224.0M	225.9M	130.7M
Liabilities And Stockholders Equity	3.4B	3.6B	4.9B	5.8B	6.8B	7.1B
Non Current Liabilities Total	327.9M	300.9M	278.3M	254.3M	351.9M	340.4M
Other Current Assets	94.2M	60.1M	126.3M	167.0M	182.8M	192.0M
Other Stockholder Equity	4.0B	4.4B	4.6B	4.8B	5.0B	5.3B
Total Liab	828.3M	949.7M	1.2B	1.5B	1.6B	1.7B
Total Current Assets	2.5B	2.4B	3.2B	4.2B	4.6B	4.9B
Short Term Debt	28.3M	15.0M	13.2M	11.4M	9.1M	8.7M
Non Currrent Assets Other	55.6M	62.8M	68.1M	106.1M	260.9M	274.0M
Net Receivables	308.8M	482.0M	616.3M	644.9M	743.6M	780.7M
Property Plant And Equipment Gross	406.6M	559.6M	751.5M	765.6M	1.0B	1.1B
Accumulated Other Comprehensive Income	(15.5M)	(15.4M)	(19.5M)	15.1M	13.1M	13.8M
Intangible Assets	193.8M	172.3M	150.8M	129.2M	123.5M	74.2M
Short Term Investments	284.9M	288.4M	290.8M	287.5M	442.7M	464.8M
Other Assets	55.6M	25.1M	467.5M	564.0M	648.6M	681.1M
Common Stock Total Equity	216K	219K	221K	223K	256.5K	154K
Common Stock	216K	219K	221K	223K	224K	157.9K
Property Plant Equipment	377.6M	559.6M	723.9M	739.3M	850.2M	892.7M
Current Deferred Revenue	312.4M	448.9M	617.0M	457.9M	1.0B	1.1B
Other Liab	271.2M	266M	244M	269.6M	310.0M	156.9M
Inventory	16.5M	36.0M	56.9M	121.0M	63.0M	66.1M
Net Tangible Assets	2.2B	2.3B	3.5B	4.1B	4.7B	4.9B
Retained Earnings Total Equity	(1.4B)	(1.7B)	(777.9M)	(437.2M)	(502.8M)	(527.9M)
Capital Surpluse	4.0B	4.4B	4.6B	4.8B	5.5B	3.4B
Non Current Liabilities Other	315.0M	318.5M	309.0M	313.8M	322.7M	278.6M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
GM	General Motors
F	Ford Motor

Additional Tools for Incyte Stock Analysis

When running Incyte's price analysis, check to measure Incyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Incyte is operating at the current time. Most of Incyte's value examination focuses on studying past and present price action to predict the probability of Incyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Incyte's price. Additionally, you may evaluate how the addition of Incyte to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Incyte Capex To Revenue vs Cost Of Revenue Analysis

Capex To Revenue vs Cost Of Revenue

Capex To Revenue vs Cost Of Revenue Correlation Analysis

Correlation Coefficient

Capex To Revenue

Cost Of Revenue

Incyte fundamental ratios Correlations

Incyte Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Incyte fundamental ratios Accounts

Also Currently Popular

Additional Tools for Incyte Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Cash
Total Current Assets	+ 1.0	Cash
Total Current Assets	+ 1.0	Cash And Short Term Investments
Total Stockholder Equity	+ 0.99	Total Assets
Cash	+ 0.99	Total Assets

Net Debt	- 0.99	Total Stockholder Equity
Total Current Assets	- 0.98	Net Debt
Cash And Short Term Investments	- 0.98	Net Debt
Cash	- 0.98	Net Debt
Net Debt	- 0.98	Total Assets
Property Plant And Equipment Gross	- 0.97	Net Debt